【Introduction】
Product Name: Human CLEC14A Antibody (Scripps Korea patent anti-CLEC14A, Research Use)
Catalog Number: NBR-0468
Target Name: CLEC14A
Trade Name: Scripps Korea patent anti-CLEC14A
Antibody Drug Description: The drug is a recombinant fully human anti-CLEC14A monoclonal antibody, being developed by Scripps Korea.
【Description】
Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS:N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG
【Gene Information】
Gene Name: CLEC14A
Synonyms: CLEC14A
Target Description: This gene encodes a member of the C-type lectin/C-type lectin-like domain (CTL/CTLD) superfamily. Members of this family share a common protein fold and have diverse functions, such as cell adhesion, cell-cell signalling, glycoprotein turnover, and roles in inflammation and immune response.
Ensembl: ENSG00000176435
Uniprot: Q86T13